| Name | Title | Contact Details |
|---|
ARCH Venture Partners is a Chicago, IL-based company in the Financial Services sector.
Envestnet Asset Management is a Chicago, IL-based company in the Financial Services sector.
Hartford Investment Management Company is a Hartford, CT-based company in the Financial Services sector.
Chrysalis Holding Company (CHC) is a privately owned corporate holding company under which the angel investing, private equity, venture capital, and real estate, interests of the Company are managed. CHC owns real asset companies with interests in: mineral deposits, forests, agricultural land, high-rise real estate, detached real estate, collectibles curation, and commodities. CHC, from time to time, owns or has interests in financial assets including: debt portfolios, capital stock, bonds, futures, options, special placement rights, factoring facilities, repurchase rights, tax assets and mezzanine facilities. Additionally, CHC is continuously funding and orchestrating the research and development of new technologies and businesses in the following areas: advanced materials engineering, application and production, energy, environmental remediation of toxins and heavy metals in soil and water, carbon dioxide and methane sequestration, wearable devices, personal anti-ballistic devices, medical devices, advanced statistical analysis, mathematical modeling, artificial intelligence and dynamic-intelligent networks, ultrasonics, entanglement, synchronized randomness, aerospace, genetic engineering, local business and artisan promotion, design, textiles, fashion, and automation. CHC is particularly dedicated to the social mission of reinventing and reinvigorating Western world inner cities and distressed populations with additional emphasis on promotion of personal property rights, education and safety in distressed nations and communities of the World.
Our team has a proven record of translating disruptive technologies into valuable business enterprises. Working closely with leading scientific and business visionaries as well as industry partners, we identify opportunities to change the future of medicine and rigorously vet those ideas through our discovery process to develop the vision, strategy and plan needed to succeed.